Physician profile
Timothy Dougherty
NPI 1164487344
$483.32
in general payments reported to CMS, 2019-2025
11 companies · $81.03 in 2025
The $81.03 reported for 2025 was more than what a typical Emergency Medicine provider received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $61.30 · 2020: $91.17 · 2021: $91.65 · 2022: $43.21 · 2023: $48.67 · 2024: $66.29 · 2025: $81.03.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $176 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $175.99 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $150.87 | 2019-2025 | |
| Abbvie INC. | $75.65 | 2019-2024 | |
| Kestra Medical Technology Services, INC. | $44.14 | 2025 | Assure Wcd |
| Allergan, INC. | $35.65 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $32.76 | 2019 | |
| Chiesi USA, INC. | $30.11 | 2020-2021 | |
| Alexion Pharmaceuticals, INC. | $28.90 | 2021 | |
| Novartis Pharmaceuticals Corporation | $24.67 | 2023 | |
| Intuitive Surgical, INC. | $24.00 | 2023 | Da Vinci Surgical System |
| Csl Behring | $20.00 | 2024 | Kcentra |
| Genzyme Corporation | $16.57 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Dougherty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.